Recurrent/Refractory B-cell Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent/Refractory B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma (NCT07367685) | The Second Affiliated Hospital of Fujian Medical University | 2026-05-01 |
Track Recurrent/Refractory B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.